| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |